Envisioning Future Therapies for T1D: Where Biology Meets Technology-Envisioning Future Therapies for T1D: Where Biology Meets Technology

Video Transcription

Video Summary

In the first video, Dr. Carol Weisham, President of the Endocrine Society, discusses the impact of the pandemic on endocrinology and the society's efforts to adapt to virtual meetings. She announces the launch of the hybrid meeting Indo 2022 and mentions other online events like Clinical Endocrine Update and Endocrine Board Review. Dr. Weisham highlights the development of special interest groups, the Endo Cares outreach program, and leadership training for underrepresented communities. She discusses digital learning opportunities and the society's advocacy efforts. Dr. Stephen Hammes introduces the features of the ENDO 2022 event, focusing on advancements in insulin, continuous glucose monitoring, closed-loop insulin delivery systems, and the use of artificial intelligence in diabetes care. He encourages attendees to explore the ENDO Expo.<br /><br />In the second video, a study is summarized where patients were divided into groups receiving advice from either an advisor or a physician, showing no significant difference in outcomes. The video also explores the benefits of clinical decision support systems, including reducing variability in care and integrating with electronic medical records. The importance of collaboration and support for healthcare providers and people with diabetes is emphasized. The second part highlights Dr. Matthias Heberk's research on modifying stem cell-derived beta cell function, discussing the differentiation process and potential applications. The video concludes with acknowledgments to the research team and funding organizations.<br /><br />No specific credits are mentioned in either video.

Keywords

Dr. Carol Weisham

Endocrine Society

virtual meetings

hybrid meeting Indo 2022

clinical decision support systems

insulin advancements

continuous glucose monitoring

closed-loop insulin delivery systems

artificial intelligence in diabetes care

ENDO Expo

collaboration

support for healthcare providers

stem cell-derived beta cell function

potential applications


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274